Retraction (Biological Psychiatry: Cognitive Neuroscience and Neuroimaging (2018) 3(3) (231–238), (S2451902217300356), (10.1016/j.bpsc.2017.02.005));Mnemonic Discrimination Deficits in First-Episode Psychosis and a Ketamine Model Suggests Dentate Gyrus Pathology Linked to N-Methyl-D-Aspartate Receptor Hypofunction

Biological Psychiatry: Cognitive Neuroscience and Neuroimaging

Volumn 3, Issue 3, 2018, Pages 231-238

  Kraguljac, Nina Vanessa ^a   Carle, Matthew ^a   Frölich, Michael A ^b   Tran, Steve ^b   Yassa, Michael A ^c   White, David Matthew ^a   Reddy, Abhishek ^a   Lahti, Adrienne Carol ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CA3; Glutamate; Hippocampal subfields; Hippocampus; Pattern completion; Pattern separation

Indexed keywords

KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; AMINO ACID RECEPTOR BLOCKING AGENT;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DENTATE GYRUS; EXPLORATORY RESEARCH; FEMALE; HUMAN; MALE; NEUROPATHOLOGY; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; POSITIVE SYNDROME; PRIORITY JOURNAL; PSYCHOSIS; RECOGNITION; TASK PERFORMANCE; YOUNG ADULT; ANTAGONISTS AND INHIBITORS; DRUG EFFECT; HIPPOCAMPUS; PERCEPTIVE DISCRIMINATION; PSYCHOLOGY;

ADULT; DISCRIMINATION (PSYCHOLOGY); EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HIPPOCAMPUS; HUMANS; KETAMINE; MALE; NEUROPSYCHOLOGICAL TESTS; PSYCHOTIC DISORDERS; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIC PSYCHOLOGY; YOUNG ADULT;

EID: 85017409472     PISSN: 24519022     EISSN: 24519030     Source Type: Journal    
DOI: 10.1016/j.bpsc.2021.10.001     Document Type: Erratum

References (75)

1. Johnston, S.T., Shtrahman, M., Parylak, S., Goncalves, J.T., Gage, F.H., Paradox of pattern separation and adult neurogenesis: A dual role for new neurons balancing memory resolution and robustness. Neurobiol Learn Mem 129 (2016), 60–68.
2. Leutgeb, J.K., Leutgeb, S., Moser, M.B., Moser, E.I., Pattern separation in the dentate gyrus and CA3 of the hippocampus. Science 315 (2007), 961–966.
3. Leutgeb, S., Leutgeb, J.K., Pattern separation, pattern completion, and new neuronal codes within a continuous CA3 map. Learn Mem 14 (2007), 745–757.
4. Rolls, E.T., Pattern separation, completion, and categorisation in the hippocampus and neocortex. Neurobiol Learn Mem 129 (2016), 4–28.
5. Treves, A., Rolls, E.T., Computational constraints suggest the need for two distinct input systems to the hippocampal CA3 network. Hippocampus 2 (1992), 189–199.
6. Rolls, E.T., The mechanisms for pattern completion and pattern separation in the hippocampus. Front Syst Neurosci, 7, 2013, 74.
7. Neunuebel, J.P., Knierim, J.J., CA3 retrieves coherent representations from degraded input: direct evidence for CA3 pattern completion and dentate gyrus pattern separation. Neuron, 81, 2014, 416–427.
8. Bakker, A., Kirwan, C.B., Miller, M., Stark, C.E., Pattern separation in the human hippocampal CA3 and dentate gyrus. Science 319 (2008), 1640–1642.
9. Lacy, J.W., Yassa, M.A., Stark, S.M., Muftuler, L.T., Stark, C.E., Distinct pattern separation related transfer functions in human CA3/dentate and CA1 revealed using high-resolution fMRI and variable mnemonic similarity. Learn Mem 18 (2011), 15–18.
10. English, D.F., Peyrache, A., Stark, E., Roux, L., Vallentin, D., Long, M.A., et al. Excitation and inhibition compete to control spiking during hippocampal ripples: Intracellular study in behaving mice. J Neurosci 34 (2014), 16509–16517.
11. Nitz, D., McNaughton, B., Differential modulation of CA1 and dentate gyrus interneurons during exploration of novel environments. J Neurophysiol 91 (2004), 863–872.
12. McHugh, T.J., Jones, M.W., Quinn, J.J., Balthasar, N., Coppari, R., Elmquist, J.K., et al. Dentate gyrus NMDA receptors mediate rapid pattern separation in the hippocampal network. Science 317 (2007), 94–99.
13. Olney, J.W., Farber, N.B., Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 52 (1995), 998–1007.
14. Coyle, J.T., Tsai, G., NMDA receptor function, neuroplasticity, and the pathophysiology of schizophrenia. Int Rev Neurobiol 59 (2004), 491–515.
15. Heckers, S., Konradi, C., GABAergic mechanisms of hippocampal hyperactivity in schizophrenia. Schizophr Res 167 (2014), 4–11.
16. Reid, M.A., White, D.M., Kraguljac, N.V., Lahti, A.C., A combined diffusion tensor imaging and magnetic resonance spectroscopy study of patients with schizophrenia. Schizophr Res 170 (2016), 341–350.
17. Hutcheson, N.L., Reid, M.A., White, D.M., Kraguljac, N.V., Avsar, K.B., Bolding, M.S., et al. Multimodal analysis of the hippocampus in schizophrenia using proton magnetic resonance spectroscopy and functional magnetic resonance imaging. Schizophr Res 140 (2012), 136–142.
18. Hutcheson, N.L., Sreenivasan, K.R., Deshpande, G., Reid, M.A., Hadley, J., White, D.M., et al. Effective connectivity during episodic memory retrieval in schizophrenia participants before and after antipsychotic medication. Human Brain Mapp 36 (2015), 1442–1457.
19. Kraguljac, N.V., Reid, M.A., White, D.M., den Hollander, J., Lahti, A.C., Regional decoupling of N-acetyl-aspartate and glutamate in schizophrenia. Neuropsychopharmacology 37 (2012), 2635–2642.
20. Kraguljac, N.V., Reid, M., White, D., Jones, R., den Hollander, J., Lowman, D., et al. Neurometabolites in schizophrenia and bipolar disorder - A systematic review and meta-analysis. Psychiatry Res 203 (2012), 111–125.
21. Kraguljac, N.V., White, D.M., Reid, M.A., Lahti, A.C., Increased hippocampal glutamate and volumetric deficits in unmedicated patients with schizophrenia. JAMA Psychiatry 70 (2013), 1294–1302.
22. Kraguljac, N.V., White, D.M., Hadley, J., Reid, M.A., Lahti, A.C., Hippocampal-parietal dysconnectivity and glutamate abnormalities in unmedicated patients with schizophrenia. Hippocampus 24 (2014), 1524–1532.
23. Kraguljac, N.V., White, D.M., Hadley, N., Hadley, J.A., Ver Hoef, L., Davis, E., et al. Aberrant hippocampal connectivity in unmedicated patients with schizophrenia and effects of antipsychotic medication: A longitudinal resting state functional MRI study. Schizophr Bull 42 (2016), 1046–1055.
24. Kraguljac, N.V., Frölich, M.A., Tran, S., White, D.M., Nichols, N., Barton-McArdle, A., et al. Ketamine modulates hippocampal neurochemistry and functional connectivity: A combined magnetic resonance spectroscopy and resting-state fMRI study in healthy volunteers. Mol Psychiatry 22 (2017), 562–569.
25. Sapkota, K., Mao, Z., Synowicki, P., Lieber, D., Liu, M., Ikezu, T., et al. GluN2D N-Methyl-d-aspartate receptor subunit contribution to the stimulation of brain activity and gamma oscillations by ketamine: Implications for schizophrenia. J Pharmacol Exp Ther, 356, 2016, 702–711.
26. Yamamoto, T., Nakayama, T., Yamaguchi, J., Matsuzawa, M., Mishina, M., Ikeda, K., et al. Role of the NMDA receptor GluN2D subunit in the expression of ketamine-induced behavioral sensitization and region-specific activation of neuronal nitric oxide synthase. Neurosci Lett 610 (2016), 48–53.
27. von Engelhardt, J., Bocklisch, C., Tonges, L., Herb, A., Mishina, M., Monyer, H., GluN2D-containing NMDA receptors-mediate synaptic currents in hippocampal interneurons and pyramidal cells in juvenile mice. Front Cell Neurosci, 9, 2015, 95.
28. Canadian Agency for Drugs and Technologies in Health. Intravenous Ketamine for the Treatment of Mental Health Disorders: A Review of Clinical Effectiveness and Guidelines. 2014, CADTH, Ottawa, Canada.
29. Lahti, A.C., Weiler, M.A., Tamara Michaelidis, B.A., Parwani, A., Tamminga, C.A., Effects of ketamine in normal and schizophrenic volunteers. Neuropsychopharmacology 25 (2001), 455–467.
30. Lahti, A.C., Koffel, B., LaPorte, D., Tamminga, C.A., Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology 13 (1995), 9–19.
31. Lahti, A.C., Holcomb, H.H., Schizophrenia, VIII: pharmacologic models. Am J Psychiatry, 160, 2003, 2091.
32. Anticevic, A., Corlett, P.R., Cole, M.W., Savic, A., Gancsos, M., Tang, Y., et al. N-methyl-D-aspartate receptor antagonist effects on prefrontal cortical connectivity better model early than chronic schizophrenia. Biol Psychiatry 77 (2015), 569–580.
33. Mathew, I., Gardin, T.M., Tandon, N., Eack, S., Francis, A.N., Seidman, L.J., et al. Medial temporal lobe structures and hippocampal subfields in psychotic disorders: Findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. JAMA Psychiatry 71 (2014), 769–777.
34. Haukvik, U.K., Westlye, L.T., Morch-Johnsen, L., Jorgensen, K.N., Lange, E.H., Dale, A.M., et al. In vivo hippocampal subfield volumes in schizophrenia and bipolar disorder. Biol Psychiatry 77 (2015), 581–588.
35. Kawano, M., Sawada, K., Shimodera, S., Ogawa, Y., Kariya, S., Lang, D.J., et al. Hippocampal subfield volumes in first episode and chronic schizophrenia. PLoS One, 10, 2015, e0117785.
36. Ho, N.F., Iglesias, J.E., Sum, M.Y., Kuswanto, C.N., Sitoh, Y.Y., De Souza, J., et al. Progression from selective to general involvement of hippocampal subfields in schizophrenia. Mol Psychiatry 22 (2017), 142–152.
37. Martinelli, C., Shergill, S.S., Clarifying the role of pattern separation in schizophrenia: The role of recognition and visual discrimination deficits. Schizophr Res 166 (2015), 328–333.
38. Das, T., Ivleva, E.I., Wagner, A.D., Stark, C.E., Tamminga, C.A., Loss of pattern separation performance in schizophrenia suggests dentate gyrus dysfunction. Schizophr Res 159 (2014), 193–197.
39. Tamminga, C.A., Psychosis is emerging as a learning and memory disorder. Neuropsychopharmacology, 38, 2013, 247.
40. Carpenter, W.T. Jr., Gold, J.M., Lahti, A.C., Queern, C.A., Conley, R.R., Bartko, J.J., et al. Decisional capacity for informed consent in schizophrenia research. Arch Gen Psychiatry 57 (2000), 533–538.
41. Stark, S.M., Yassa, M.A., Lacy, J.W., Stark, C.E., A task to assess behavioral pattern separation (BPS) in humans: Data from healthy aging and mild cognitive impairment. Neuropsychologia 51 (2013), 2442–2449.
42. Nurnberger, J.I. Jr., Blehar, M.C., Kaufmann, C.A., York-Cooler, C., Simpson, S.G., Harkavy-Friedman, J., et al. Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch Gen Psychiatry 51 (1994), 849–859.
43. Yassa, M.A., Lacy, J.W., Stark, S.M., Albert, M.S., Gallagher, M., Stark, C.E., Pattern separation deficits associated with increased hippocampal CA3 and dentate gyrus activity in nondemented older adults. Hippocampus 21 (2011), 968–979.
44. Adriano, F., Caltagirone, C., Spalletta, G., Hippocampal volume reduction in first-episode and chronic schizophrenia: A review and meta-analysis. Neuroscientist 18 (2012), 180–200.
45. Kuhn, S., Musso, F., Mobascher, A., Warbrick, T., Winterer, G., Gallinat, J., Hippocampal subfields predict positive symptoms in schizophrenia: First evidence from brain morphometry. Transl Psychiatry, 2, 2012, e127.
46. Kirov, I.I., Hardy, C.J., Matsuda, K., Messinger, J., Cankurtaran, C.Z., Warren, M., et al. In vivo 7 Tesla imaging of the dentate granule cell layer in schizophrenia. Schizophr Res 147 (2013), 362–367.
47. Narr, K.L., Thompson, P.M., Szeszko, P., Robinson, D., Jang, S., Woods, R.P., et al. Regional specificity of hippocampal volume reductions in first-episode schizophrenia. Neuroimage 21 (2004), 1563–1575.
48. Zierhut, K.C., Grassmann, R., Kaufmann, J., Steiner, J., Bogerts, B., Schiltz, K., Hippocampal CA1 deformity is related to symptom severity and antipsychotic dosage in schizophrenia. Brain 136 (2013), 804–814.
49. Ho, B.C., Alicata, D., Ward, J., Moser, D.J., O׳Leary, D.S., Arndt, S., et al. Untreated initial psychosis: Relation to cognitive deficits and brain morphology in first-episode schizophrenia. Am J Psychiatry 160 (2003), 142–148.
50. Walker, M.A., Highley, J.R., Esiri, M.M., McDonald, B., Roberts, H.C., Evans, S.P., et al. Estimated neuronal populations and volumes of the hippocampus and its subfields in schizophrenia. Am J Psychiatry 159 (2002), 821–828.
51. Schmitt, A., Steyskal, C., Bernstein, H.G., Schneider-Axmann, T., Parlapani, E., Schaeffer, E.L., et al. Stereologic investigation of the posterior part of the hippocampus in schizophrenia. Acta Neuropathol 117 (2009), 395–407.
52. Konradi, C., Yang, C.K., Zimmerman, E.I., Lohmann, K.M., Gresch, P., Pantazopoulos, H., et al. Hippocampal interneurons are abnormal in schizophrenia. Schizophr Res 131 (2011), 165–173.
53. Reif, A., Fritzen, S., Finger, M., Strobel, A., Lauer, M., Schmitt, A., et al. Neural stem cell proliferation is decreased in schizophrenia, but not in depression. Mol Psychiatry 11 (2006), 514–522.
54. Steiner, J., Brisch, R., Schiltz, K., Dobrowolny, H., Mawrin, C., Krzyzanowska, M., et al. GABAergic system impairment in the hippocampus and superior temporal gyrus of patients with paranoid schizophrenia: A post-mortem study. Schizophr Res 177 (2016), 10–17.
55. Schobel, S.A., Lewandowski, N.M., Corcoran, C.M., Moore, H., Brown, T., Malaspina, D., et al. Differential targeting of the CA1 subfield of the hippocampal formation by schizophrenia and related psychotic disorders. Arch Gen Psychiatry 66 (2009), 938–946.
56. Talati, P., Rane, S., Kose, S., Blackford, J.U., Gore, J., Donahue, M.J., et al. Increased hippocampal CA1 cerebral blood volume in schizophrenia. Neuroimage Clin 5 (2014), 359–364.
57. Schobel, S.A., Chaudhury, N.H., Khan, U.A., Paniaqua, B., Styner, M.A., Asllani, I., et al. Imaging patients with psychosis and a mouse model establishes a spreading pattern of hippocampal dysfunction and implicates glutamate as a driver. Neuron 78 (2013), 81–93.
58. Li, W., Ghose, S., Gleason, K., Begovic, A., Perez, J., Bartko, J., et al. Synaptic proteins in the hippocampus indicative of increased neuronal activity in CA3 in schizophrenia. Am J Psychiatry 172 (2015), 373–382.
59. Umbricht, D., Schmid, L., Koller, R., Vollenweider, F.X., Hell, D., Javitt, D.C., Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: Implications for models of cognitive deficits in schizophrenia. Arch Gen Psychiatry 57 (2000), 1139–1147.
60. Stefanovic, A., Brandner, B., Klaassen, E., Cregg, R., Nagaratnam, M., Bromley, L.M., et al. Acute and chronic effects of ketamine on semantic priming: Modeling schizophrenia?. J Clin Psychopharmacol 29 (2009), 124–133.
61. Parwani, A., Weiler, M.A., Blaxton, T.A., Warfel, D., Hardin, M., Frey, K., et al. The effects of a subanesthetic dose of ketamine on verbal memory in normal volunteers. Psychopharmacology 183 (2005), 265–274.
62. Rowland, L.M., Astur, R.S., Jung, R.E., Bustillo, J.R., Lauriello, J., Yeo, R.A., Selective cognitive impairments associated with NMDA receptor blockade in humans. Neuropsychopharmacology 30 (2005), 633–639.
63. LaPorte, D.J., Blaxton, T.A., Michaelidis, T., Robertson, D.U., Weiler, M.A., Tamminga, C.A., et al. Subtle effects of ketamine on memory when administered following stimulus presentation. Psychopharmacology 180 (2005), 385–390.
64. Passie, T., Karst, M., Wiese, B., Emrich, H.M., Schneider, U., Effects of different subanesthetic doses of (S)-ketamine on neuropsychology, psychopathology, and state of consciousness in man. Neuropsychobiology 51 (2005), 226–233.
65. Day, M., Langston, R., Morris, R.G., Glutamate-receptor-mediated encoding and retrieval of paired-associate learning. Nature 424 (2003), 205–209.
66. Kannangara, T.S., Eadie, B.D., Bostrom, C.A., Morch, K., Brocardo, P.S., Christie, B.R., GluN2A-/- mice lack bidirectional synaptic plasticity in the dentate gyrus and perform poorly on spatial pattern separation tasks. Cereb Cortex 25 (2015), 2102–2113.
67. Stan, A.D., Ghose, S., Zhao, C., Hulsey, K., Mihalakos, P., Yanagi, M., et al. Magnetic resonance spectroscopy and tissue protein concentrations together suggest lower glutamate signaling in dentate gyrus in schizophrenia. Mol Psychiatry 20 (2015), 433–439.
68. Hanson, J.E., Madison, D.V., Imbalanced pattern completion vs. separation in cognitive disease: Network simulations of synaptic pathologies predict a personalized therapeutics strategy. BMC Neurosci, 11, 2010, 96.
69. Faghihi, F., Moustafa, A.A., A computational model of pattern separation efficiency in the dentate gyrus with implications in schizophrenia. Front Syst Neurosci, 9, 2015, 42.
70. Berron, D., Schutze, H., Maass, A., Cardenas-Blanco, A., Kuijf, H.J., Kumaran, D., et al. Strong evidence for pattern separation in human dentate gyrus. J Neurosci, 36, 2016, 7569–7579.
71. Kesner, R.P., Kirk, R.A., Yu, Z., Polansky, C., Musso, N.D., Dentate gyrus supports slope recognition memory, shades of grey-context pattern separation and recognition memory, and CA3 supports pattern completion for object memory. Neurobiol Learn Mem 129 (2016), 29–37.
72. Kim, J., Yassa, M.A., Assessing recollection and familiarity of similar lures in a behavioral pattern separation task. Hippocampus 23 (2013), 287–294.
73. Yassa, M.A., Stark, S.M., Bakker, A., Albert, M.S., Gallagher, M., Stark, C.E., High-resolution structural and functional MRI of hippocampal CA3 and dentate gyrus in patients with amnestic mild cognitive impairment. Neuroimage 51 (2010), 1242–1252.
74. Liu, K.Y., Gould, R.L., Coulson, M.C., Ward, E.V., Howard, R.J., Tests of pattern separation and pattern completion in humans-A systematic review. Hippocampus 26 (2016), 705–717.
75. Pidgeon, L.M., Morcom, A.M., Cortical pattern separation and item-specific memory encoding. Neuropsychologia 85 (2016), 256–271.